Yao Wang's Q1 FY2024 net profit is -13.775 million yuan, a 56.66% increase year-over-year.

K-LinePoet · 2026-02-24T04:23:20+00:00

On May 23, Yiyao.com (Stock Code: YI) announced its financial report, showing that the company's net profit attributable to ordinary shareholders for the first quarter of fiscal year 2024 was -13.775 million yuan, a year-on-year increase of 56.66%; operating revenue was 3.528 billion yuan, a decrease of 4.55% year-on-year.Yiyao.com Limited(, formerly known as Yiyao.com), was established in July 2010. It is affiliated with the 111 Group and is a medical platform used by a vast number of users. It is also one of China's first legitimate online pharmacies to obtain the "Internet Drug Transaction Permit" issued by the National Medical Products Administration. It provides customers with a one-stop "Medical + Pharmacy" convenient experience. Yiyao.com has always been committed to using internet thinking to enter the digital and mobile healthcare field, solving the problems of "difficult to see a doctor, expensive medicine" for Chinese people, and creating greater social value. Relying on 111

K-LinePoet

2026-02-24 04:23:20

On May 23rd, 1YaoNet (Stock Code: YI) announced its financial report, showing that the company’s net profit attributable to common shareholders for the first quarter of fiscal year 2024 was -13.775 million yuan, a 56.66% increase year-over-year; operating revenue was 3.528 billion yuan, a 4.55% decrease year-over-year.

1YaoNet Co., Ltd. (formerly known as YiYaoNet) was founded in July 2010 and is part of the 111 Group. It is a widely used medical platform with a large user base and is one of China’s first online pharmacies licensed by the National Medical Products Administration to operate Internet drug transactions, providing customers with a one-stop “Medical + Pharmacy” convenient experience. 1YaoNet has always been committed to using internet thinking to enter the digital and mobile healthcare fields, solving the problems of “difficult medical consultations and expensive medicines” for Chinese people, and creating greater social value. Relying on the core advantages of 111 Group’s cloud platform solutions, intelligent supply chain, big data, and medical expertise, 1YaoNet has built core competitiveness in platform operation, product procurement, supply chain management, medical services, customer experience, and warehousing and distribution. Leveraging unique resources and platform advantages from direct sourcing of medicines and online e-commerce, 1YaoNet sincerely offers benefits to customers, guaranteeing the same quality of medicines at lower prices, attracting more patients to purchase medicines online. Through direct cooperation with pharmaceutical manufacturers, 1YaoNet reduces middlemen in supply chain management, achieving an efficient and transparent management model, while ensuring genuine products and safety for customers.

(Source: Tonghuashun (300033) iFinD)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.